![A 49-year-old man with diabetes mellitus and prostate cancer (Gleason 6) treated with radical prostatectomy. ^18^F-fluorocholine PET/CT was requested for biochemical recurrence (prostate specific antigen of 0.84 ng/mL). No pathological locations related to the oncological disease were observed on ^18^F-fluorocholine PET/CT. However, increased metabolism in lung opacities (arrowheads) and some mediastinal lymph nodes (arrows) were observed. Patient was completely asymptomatic at the moment of PET/CT and had only mild cough, 2 weeks ago. Patient was referred to emergency department. Real-time polymerase chain reaction, to detect viral nucleotides from specimens obtained from nasopharyngeal swab, was positive for COVID-19. Based on COVID-19 having pulmonary tropism, pneumonia seems to be very prevalent, up to 56% or 80%, depending on the series.^[@bib1],[@bib2]^ The most discriminating features for COVID-19 pneumonia included a peripheral and lower zone dominance distribution and bilateral involvement (arrowheads). The morphological features are diverse, consisting of ground-glass opacity, reticular pattern, and vascular thickening, among others.^[@bib3],[@bib4]^ Although COVID-19 infections do not seem to be accompanied by lymphadenopathy in terms of nodal enlargement detected on standard CT,^[@bib5],[@bib6]^ ^18^F-FDG and ^18^F-fluorocholine can detect lymphadenitis.^[@bib7],[@bib8]^](rlu-publish-ahead-of-print-10.1097.rlu.0000000000003189-g001){#FU1}

![Chest x-ray (CXR) performed as part of clinical triage in the emergency department was reported as normal. Despite the moderate sensitivity of baseline CXR in the detection of pneumonia, CXR is the first-line triage tool in most European hospitals.^[@bib2]^ Although CXR findings mirror those previously described for CT, the latter is more sensitive in the diagnosis of viral pneumonia especially during the early stages of disease development.^[@bib9]^ Although ^18^F-FDG PET/CT plays an important role in evaluating inflammatory and infectious pulmonary diseases,^[@bib10],[@bib11]^ ^18^F-fluorocholine is able to demonstrate the lung inflammatory burden in COVID-19 infection and an important tool in order to take decisions related to epidemiological and clinical recommendations given to patients.^[@bib12]^](rlu-publish-ahead-of-print-10.1097.rlu.0000000000003189-g002){#FU2}
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